EPISODE · Mar 1, 2022 · 27 MIN
Episode 78: Regulatory and Commercial Considerations for Hemp-Derived CBD
from Cannabis Tech Talks
How do cannabis chemotypes shape market access? What’s the FDA’s position on CBD as a consumer product ingredient? Listen in as Dr. Duffy MacKay shares what he’s learned as the senior vice president of scientific and regulatory affairs at CV Sciences, a CBD company available in more than 7,300 retail locations. This business-focused discussion is adapted from a session at the Emerge Virtual Cannabis Conference. Are you still reading? Start listening and join the conversation around hemp-derived CBD. Cannabis Tech Talks are brought to you thanks to the support of Polyscience. Discover how Polyscience is changing the world of temperature control by visiting Polyscience.com.
What this episode covers
How do cannabis chemotypes shape market access? What’s the FDA’s position on CBD as a consumer product ingredient? Listen in as Dr. Duffy MacKay shares what he’s learned as the senior vice president of scientific and regulatory affairs at CV Sciences, a CBD company available in more than 7,300 retail locations. This business-focused discussion is adapted from a session at the Emerge Virtual Cannabis Conference. Are you still reading? Start listening and join the conversation around hemp-derived CBD. Cannabis Tech Talks are brought to you thanks to the support of Polyscience. Discover how Polyscience is changing the world of temperature control by visiting Polyscience.com.
NOW PLAYING
Episode 78: Regulatory and Commercial Considerations for Hemp-Derived CBD
No transcript for this episode yet
Similar Episodes
Feb 1, 2025 ·168m
Aug 7, 2024 ·58m